Literature DB >> 2040184

Effect of recombinant human erythropoietin treatment on renal anemia and body growth of children with end-stage renal disease. The European Multicenter Study Group.

P Scigalla1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2040184     DOI: 10.1159/000419530

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  8 in total

1.  The use of darbepoetin in infants with chronic renal impairment.

Authors:  Anne M Durkan; Laura E Keating; Annette Vigneux; Denis F Geary
Journal:  Pediatr Nephrol       Date:  2006-03-25       Impact factor: 3.714

2.  Intraperitoneal treatment with darbepoetin for children on peritoneal dialysis.

Authors:  Yvonne Rijk; Renske Raaijmakers; Nicole van de Kar; Cornelis Schröder
Journal:  Pediatr Nephrol       Date:  2006-11-16       Impact factor: 3.714

Review 3.  Use of agents stimulating erythropoiesis in digestive diseases.

Authors:  Rosario Moreno López; Beatriz Sicilia Aladrén; Fernando Gomollón García
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

4.  Pharmacokinetics of recombinant human erythropoietin applied subcutaneously to children with chronic renal failure.

Authors:  A Braun; R Ding; C Seidel; T Fies; A Kurtz; K Schärer
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

5.  Non-cardiac benefits of human recombinant erythropoietin in end stage renal failure and anaemia.

Authors:  K P Morris; J Sharp; S Watson; M G Coulthard
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

6.  Recombinant human erythropoietin for the treatment of renal anaemia in children: no justification for bodyweight-adjusted dosage.

Authors:  Ruediger E Port; Daniela Kiepe; Michael Van Guilder; Roger W Jelliffe; Otto Mehls
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 7.  The effects of recombinant human erythropoietin on growth and nutritional status.

Authors:  K Jabs
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

Review 8.  Use of erythropoiesis-stimulating agents in children with chronic kidney disease: a systematic review.

Authors:  Gordon Bruce; Peter Schulga; Ben C Reynolds
Journal:  Clin Kidney J       Date:  2022-02-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.